DAHUA-TECHNOLOGY
31.8.2022 14:46:35 CEST | Business Wire | Press release
Dahua Technology, a world-leading video-centric smart IoT solution and service provider, officially released the Dahua DeepHub Pro Series at its online global launch. Equipped with ultra-low-latency writing, one-tap wireless screen sharing, built-in camera & microphone and other advanced AI functions, Dahua DeepHub delivers a flexible, multimedia approach to teaching and conferencing, providing participants with an immersive, interactive and content-rich experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220831005338/en/
Traditional methods of learning in classroom settings have several challenges, including poor interaction between students and teachers, and potentially poor visual clarity from some positions in the room. Dahua’s DeepHub interactive whiteboard is designed to provide a content-rich, interactive and stimulating learning experience in schools and colleges, consigning to history conventional whiteboards and other presenting platforms. (Photo: Business Wire)
“Dahua DeepHub combines Dahua's advantages in core technologies such as video, audio and high-definition video transmission to offer a complete range of smart interactive whiteboards. From entry-level Lite Series to high-end Pro Series, this product meets the growing digitalization and collaboration demands of both business and education customer groups in the modern-day IoT world,” said Josh Wang, Product Manager of Dahua DeepHub.
The online launch highlighted several features of Dahua DeepHub. For instance, it utilizes Zero Air Gap Technology on the screen to reduce parallax for clearer image display. Ink signal latency is also optimized, providing approximately 50 pages or 1,500 strokes of continuous writing.
To enhance visual output and operation, Dahua DeepHub utilizes powerful AI functions including Handwriting Recognition that can recognize intelligible handwritten texts and shapes, and Gesture Control to easily operate the device anywhere in the room. It can even automatically detect and focus on the current speaker for better interaction. Also, on-screen materials can be displayed onto other devices in the room and be edited in real-time through the Two-way Sharing function.
Dahua DeepHub also supports SIMS device management system, allowing IT personnel to fully grasp the operating status of the device. It has flagship smartphone-level chip equipped with 8 execution engine GPU to ensure image rendering capability, and an NPU that offers five tops computing power – another unprecedented feature in the industry.
Furthermore, it operates using a single Type C cable that can replace HDMI, audio and touchscreen cables, and can supply power to external devices. It supports fingerprint access control, AirPlay, Chromecast, Miracast, and Eshare wireless connections, as well as Android 11 and Windows 10 operating systems that can be flexibly switched.
The complete range of Dahua DeepHub Series marks a step forward towards Dahua's goal of empowering cities and enterprises with digital transformation through smart IoT technologies. With more models in the upcoming months, Dahua will continue to deliver better digital experience to global customers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220831005338/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release
Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin
DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 11:21:00 CEST | Press release
Poster presented at ESMO Breast Cancer 2026: Exploring health policy and real-world treatment strategies for early-stage HER2-positive breast cancer across Europe. The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom